# PLUS THERAPEUTICS, INC. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/plus-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 23 | | Claims under review | 1 | | Evidence records | 6 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-20T04:49:14.827895+00:00 | | Last reviewed | 2026-10-20T04:49:14.827895+00:00 | ## Identity - Legal name: PLUS THERAPEUTICS, INC. - Display name: PLUS THERAPEUTICS, INC. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-21T04:35:15.453646+00:00 | | Completeness | 0.409 | | Record Quality | 0.836 | | Directors | 6 | | Committees | 5 | | Governance events | 14 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - An van Es-Johansson, M.D.: Director. Status: current. Independent: true. Since: 2020-01-01. claim_id=alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:leadership_role:5 - Howard Clowes: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Audit (member); Audit; Compensation; Nominating and Governance · Chair (member); Compensation (member); Nominating and Governance (chair). claim_id=alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:leadership_role:6 - Kyle Carver, M.B.A., C.P.A.: Director. Status: current. Independent: true. Since: 2025-01-01. Committees: Audit (chair); Audit · Chair; Compensation (member); Compensation (member). claim_id=alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:leadership_role:7 - Marc H. Hedrick, M.D.: Director. Status: current. Independent: false. Since: 2002-01-01. claim_id=alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:leadership_role:8 - Richard J. Hawkins: Director. Status: current. Independent: true. Since: 2007-01-01. Committees: Nominating and Governance (member). claim_id=alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:leadership_role:9 - Ronald A. Andrews: Director. Status: current. Independent: true. Since: 2026-01-01. Committees: Nominating and Governance (member). claim_id=alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:leadership_role:10 ## Committees - Audit (audit). Chair: Kyle Carver, M.B.A., C.P.A.. Members: Kyle Carver, M.B.A., C.P.A. (chair, current); Howard Clowes (member, current). committee_id=alpha:committee:plus-therapeutics-inc:audit - Audit · Chair; Compensation (audit). Chair: NOT_PUBLISHED. Members: Kyle Carver, M.B.A., C.P.A. (member, current). committee_id=alpha:committee:plus-therapeutics-inc:audit-chair-compensation - Audit; Compensation; Nominating and Governance · Chair (audit). Chair: NOT_PUBLISHED. Members: Howard Clowes (member, current). committee_id=alpha:committee:plus-therapeutics-inc:audit-compensation-nominating-and-governance-chair - Compensation (compensation). Chair: NOT_PUBLISHED. Members: Howard Clowes (member, current); Kyle Carver, M.B.A., C.P.A. (member, current). committee_id=alpha:committee:plus-therapeutics-inc:compensation - Nominating and Governance (nominating_governance). Chair: Howard Clowes. Members: Howard Clowes (chair, current); Richard J. Hawkins (member, current); Ronald A. Andrews (member, current). committee_id=alpha:committee:plus-therapeutics-inc:nominating-and-governance ## Executive leadership - Andrew Sims: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:leadership_role:11 - Marc H. Hedrick, M.D.: President and Chief Executive Officer [CEO]. Status: current. claim_id=alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:leadership_role:12 - Norman LaFrance, M.D.: Chief Medical Officer. Status: current. claim_id=alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:leadership_role:13 ## Governance events - CFO_CHANGED: Andrew Sims executive of PLUS THERAPEUTICS, INC., effective 2026-03-31. Effective: 2026-03-31. Detected: 2026-10-20T04:49:14.827895+00:00. event_id=alpha:event:transition:443c1p157mcn1 - CEO_CHANGED: Marc H. Hedrick, M.D. executive of PLUS THERAPEUTICS, INC., effective 2026-03-31. Effective: 2026-03-31. Detected: 2026-10-20T04:49:14.827895+00:00. event_id=alpha:event:transition:1erdft218svet0 - EXECUTIVE_APPOINTED: Norman LaFrance, M.D. executive of PLUS THERAPEUTICS, INC., effective 2026-03-31. Effective: 2026-03-31. Detected: 2026-10-20T04:49:14.827895+00:00. event_id=alpha:event:transition:uo0ikn12c95er - DIRECTOR_APPOINTED: Ronald A. Andrews seat on PLUS THERAPEUTICS, INC., effective 2026-01-01. Effective: 2026-01-01. Detected: 2026-10-20T04:49:14.827895+00:00. event_id=alpha:event:transition:ty23mfoysw2h - DIRECTOR_APPOINTED: Kyle Carver, M.B.A., C.P.A. seat on PLUS THERAPEUTICS, INC., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-20T04:49:14.827895+00:00. event_id=alpha:event:transition:b6vbko5mkaao - COMMITTEE_CREATED: Audit · Chair; Compensation committee of PLUS THERAPEUTICS, INC., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-20T04:49:14.827895+00:00. event_id=alpha:event:transition:y6o4n41v898sg - COMMITTEE_MEMBER_ADDED: Kyle Carver, M.B.A., C.P.A. member of Audit · Chair; Compensation, effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-20T04:49:14.827895+00:00. event_id=alpha:event:transition:104gxz6lmqu9g - DIRECTOR_APPOINTED: An van Es-Johansson, M.D. seat on PLUS THERAPEUTICS, INC., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-20T04:49:14.827895+00:00. event_id=alpha:event:transition:yare3jvv3kbj - DIRECTOR_APPOINTED: Howard Clowes seat on PLUS THERAPEUTICS, INC., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-20T04:49:14.827895+00:00. event_id=alpha:event:transition:k4amgikhzp00 - COMMITTEE_CREATED: Audit; Compensation; Nominating and Governance · Chair committee of PLUS THERAPEUTICS, INC., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-20T04:49:14.827895+00:00. event_id=alpha:event:transition:w76o462antw0 - COMMITTEE_MEMBER_ADDED: Howard Clowes member of Audit; Compensation; Nominating and Governance · Chair, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-20T04:49:14.827895+00:00. event_id=alpha:event:transition:cwmjwayd24ka - DIRECTOR_APPOINTED: Richard J. Hawkins seat on PLUS THERAPEUTICS, INC., effective 2007-01-01. Effective: 2007-01-01. Detected: 2026-10-20T04:49:14.827895+00:00. event_id=alpha:event:transition:atxwsyx5lo06 - COMMITTEE_MEMBER_ADDED: Richard J. Hawkins member of Nominating and Governance, effective 2007-01-01. Effective: 2007-01-01. Detected: 2026-10-20T04:49:14.827895+00:00. event_id=alpha:event:transition:jf3zewimtrkg - DIRECTOR_APPOINTED: Marc H. Hedrick, M.D. seat on PLUS THERAPEUTICS, INC., effective 2002-01-01. Effective: 2002-01-01. Detected: 2026-10-20T04:49:14.827895+00:00. event_id=alpha:event:transition:xc28pe14q14pm ## Scoped resources - `alpha://company/plus-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/plus-therapeutics-inc?format=record - `alpha://company/plus-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/plus-therapeutics-inc?format=record§ion=identity - `alpha://company/plus-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/plus-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/plus-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/plus-therapeutics-inc?format=record§ion=board - `alpha://company/plus-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/plus-therapeutics-inc?format=record§ion=committees - `alpha://company/plus-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/plus-therapeutics-inc?format=record§ion=leadership - `alpha://company/plus-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/plus-therapeutics-inc?format=record§ion=ownership - `alpha://company/plus-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/plus-therapeutics-inc?format=record§ion=financials - `alpha://company/plus-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/plus-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/plus-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/plus-therapeutics-inc?format=record§ion=compensation - `alpha://company/plus-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/plus-therapeutics-inc?format=record§ion=governance - `alpha://company/plus-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/plus-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/plus-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/plus-therapeutics-inc?format=record§ion=audit - `alpha://company/plus-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/plus-therapeutics-inc?format=record§ion=legal - `alpha://company/plus-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/plus-therapeutics-inc?format=record§ion=risk - `alpha://company/plus-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/plus-therapeutics-inc?format=record§ion=cyber - `alpha://company/plus-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/plus-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/plus-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/plus-therapeutics-inc?format=record§ion=agents - `alpha://company/plus-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/plus-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/plus-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/plus-therapeutics-inc?format=record§ion=events - `alpha://company/plus-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/plus-therapeutics-inc?format=record§ion=relationships - `alpha://company/plus-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/plus-therapeutics-inc?format=record§ion=assessments - `alpha://company/plus-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/plus-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:committee_appointment:15: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:kyle-guse-esq-mba-cpa","name":"Kyle Carver, M.B.A., C.P.A."},"source_id":"board_seats"}` - Claim alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:committee_appointment:16: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:howard-clowes","name":"Howard Clowes"},"source_id":"board_seats"}` - Claim alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:howard-clowes","name":"Howard Clowes"},"source_id":"board_seats"}` - Claim alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:kyle-guse-esq-mba-cpa","name":"Kyle Carver, M.B.A., C.P.A."},"source_id":"board_seats"}` - Claim alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:howard-clowes","name":"Howard Clowes"},"source_id":"board_seats"}` - Claim alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:richard-j-hawkins","name":"Richard J. Hawkins"},"source_id":"board_seats"}` - Claim alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:committee_appointment:23: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:ronald-a-andrews","name":"Ronald A. Andrews"},"source_id":"board_seats"}` ## Leadership - An van Es-Johansson, M.D.: Director. Claim: alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:leadership_role:5. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f2b02ec61a4ee61f346e60ababa607ae17872bfb0a9a4a686290a8e2ba5fac5f. - Howard Clowes: Director, Audit; Compensation; Nominating and Governance · Chair. Claim: alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:leadership_role:6. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f2b02ec61a4ee61f346e60ababa607ae17872bfb0a9a4a686290a8e2ba5fac5f. - Kyle Carver, M.B.A., C.P.A.: Director, Audit · Chair; Compensation. Claim: alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:leadership_role:7. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f2b02ec61a4ee61f346e60ababa607ae17872bfb0a9a4a686290a8e2ba5fac5f. - Marc H. Hedrick, M.D.: Director. Claim: alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:leadership_role:8. Valid from: 2002-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f2b02ec61a4ee61f346e60ababa607ae17872bfb0a9a4a686290a8e2ba5fac5f. - Richard J. Hawkins: Director, Nominating and Governance. Claim: alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:leadership_role:9. Valid from: 2007-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f2b02ec61a4ee61f346e60ababa607ae17872bfb0a9a4a686290a8e2ba5fac5f. - Ronald A. Andrews: Director, Nominating and Governance. Claim: alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:leadership_role:10. Valid from: 2026-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f2b02ec61a4ee61f346e60ababa607ae17872bfb0a9a4a686290a8e2ba5fac5f. - Andrew Sims: Chief Financial Officer. Claim: alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:leadership_role:11. Valid from: 2026-03-31. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7db370acb3f9edf395d211e13878566ea0d4afdae71f3d8be3979cb6a84a03d3. - Marc H. Hedrick, M.D.: President and Chief Executive Officer. Claim: alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:leadership_role:12. Valid from: 2026-03-31. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9e1bfa997e17a7223f1c8b883c7fb8923227a061a717ad974749ec626efefd26. - Norman LaFrance, M.D.: Chief Medical Officer. Claim: alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:leadership_role:13. Valid from: 2026-03-31. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:2e0d8114d132142ae328cf5ccee005f836eae1f0f6a97e34b71a200ac33f23dd. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Kyle Carver, M.B.A., C.P.A.; Members Kyle Carver, M.B.A., C.P.A. (Chair); Howard Clowes. Claim: alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:committee_record:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6bac83f1723b5914be57f8a36a8c8c9eb816fad30ed1b5c9261518d65b2ab8ea. - Compensation: Chair not stated; Members Howard Clowes; Kyle Carver, M.B.A., C.P.A.. Claim: alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:committee_record:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6bac83f1723b5914be57f8a36a8c8c9eb816fad30ed1b5c9261518d65b2ab8ea. - Nominating and Governance: Chair Howard Clowes; Members Howard Clowes (Chair); Richard J. Hawkins; Ronald A. Andrews. Claim: alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:committee_record:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6bac83f1723b5914be57f8a36a8c8c9eb816fad30ed1b5c9261518d65b2ab8ea. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - PLUS THERAPEUTICS, INC.. Claim: alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d5bc8301b40944e66d0b6a3e4f359685185a57923fc9c1fc2446a14d2b7f93b6. ## Entity Status - Public listing published. Claim: alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d5bc8301b40944e66d0b6a3e4f359685185a57923fc9c1fc2446a14d2b7f93b6. ## Published Fact - US. Claim: alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d5bc8301b40944e66d0b6a3e4f359685185a57923fc9c1fc2446a14d2b7f93b6. ## Committee Appointment - Kyle Carver, M.B.A., C.P.A.: chair, Audit. Claim: alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:committee_appointment:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6bac83f1723b5914be57f8a36a8c8c9eb816fad30ed1b5c9261518d65b2ab8ea. - Howard Clowes: member, Audit. Claim: alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:committee_appointment:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6bac83f1723b5914be57f8a36a8c8c9eb816fad30ed1b5c9261518d65b2ab8ea. - Howard Clowes: member, Compensation. Claim: alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6bac83f1723b5914be57f8a36a8c8c9eb816fad30ed1b5c9261518d65b2ab8ea. - Kyle Carver, M.B.A., C.P.A.: member, Compensation. Claim: alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6bac83f1723b5914be57f8a36a8c8c9eb816fad30ed1b5c9261518d65b2ab8ea. - Howard Clowes: chair, Nominating and Governance. Claim: alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6bac83f1723b5914be57f8a36a8c8c9eb816fad30ed1b5c9261518d65b2ab8ea. - Richard J. Hawkins: member, Nominating and Governance. Claim: alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6bac83f1723b5914be57f8a36a8c8c9eb816fad30ed1b5c9261518d65b2ab8ea. - Ronald A. Andrews: member, Nominating and Governance. Claim: alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6bac83f1723b5914be57f8a36a8c8c9eb816fad30ed1b5c9261518d65b2ab8ea. ## Security Listing - PSTV (NASDAQ). Claim: alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:security_listing:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d5bc8301b40944e66d0b6a3e4f359685185a57923fc9c1fc2446a14d2b7f93b6. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:d5bc8301b40944e66d0b6a3e4f359685185a57923fc9c1fc2446a14d2b7f93b6: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/plus-therapeutics-inc). - alpha:projection-evidence:document:f2b02ec61a4ee61f346e60ababa607ae17872bfb0a9a4a686290a8e2ba5fac5f: [PLUS THERAPEUTICS, INC. DEF 14A 2026-03-31](https://www.sec.gov/Archives/edgar/data/1095981/000119312526134646/pstv-20260331.htm). - alpha:projection-evidence:document:7db370acb3f9edf395d211e13878566ea0d4afdae71f3d8be3979cb6a84a03d3: [PSTV DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1095981/000119312526134646/pstv-20260331.htm). - alpha:projection-evidence:document:9e1bfa997e17a7223f1c8b883c7fb8923227a061a717ad974749ec626efefd26: [PSTV DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1095981/000119312526134646/pstv-20260331.htm). - alpha:projection-evidence:document:2e0d8114d132142ae328cf5ccee005f836eae1f0f6a97e34b71a200ac33f23dd: [PSTV DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1095981/000119312526134646/pstv-20260331.htm). - alpha:projection-evidence:6bac83f1723b5914be57f8a36a8c8c9eb816fad30ed1b5c9261518d65b2ab8ea: [Audit](https://www.sec.gov/Archives/edgar/data/1095981/000119312526134646/pstv-20260331.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/plus-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/plus-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/plus-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/plus-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/plus-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-21T04:35:15.22256+00:00; recorded 2026-10-21T04:35:15.22256+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.